OIG report accuses FDA of not following policies for foreign drug inspections
A new report from the US Department of Health and Human Services’ Office of Inspector General accuses the FDA of not following its policies around foreign drug inspections, and recommends some improvements.
The OIG report, released on Thursday, found that the FDA has not always followed its policies and procedures for foreign for-cause drug inspections, and that the agency allegedly misplaced documents to prove its lead investigators completed their required training.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.